SUNDAR NA SANKARAN
Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology HENDERSON, NV NPI 1992772909
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology NV Medtronic, Inc. All categories
General Payments — all program years on this page
$12,428.99
- Category: General Payments
- Program years: PY2018–2024
- Record count: 210
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $7,881.37 across 34 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,650.00 | 2 |
| Food and Beverage | $1,231.37 | 32 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $7,317.33 | 8 |
| Otsuka America Pharmaceutical, Inc. | $112.32 | 6 |
| Amgen Inc. | $87.37 | 3 |
| Acerta Pharma LLC | $59.18 | 3 |
| Relypsa, Inc. | $47.29 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $44.76 | 2 |
| Mozarc Medical US LLC | $39.65 | 2 |
| ANI Pharmaceuticals, Inc. | $26.84 | 1 |
| BARD PERIPHERAL VASCULAR, INC. | $25.58 | 1 |
| AKEBIA THERAPEUTICS INC | $25.56 | 1 |
| CALLIDITAS THERAPEUTICS US INC. | $24.35 | 1 |
| Lilly USA, LLC | $19.33 | 1 |
| Fresenius USA Marketing, Inc. | $17.96 | 1 |
| OPKO Pharmaceuticals, LLC | $17.67 | 1 |
| GlaxoSmithKline, LLC. | $16.18 | 1 |
By program year
Records — PY2024 (34)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.